Acute changes in systemic blood pressure and urine output of conscious rats following exchange transfusion with diaspirin-crosslinked hemoglobin solution.
This report describes acute changes in systemic blood pressure and urine output observed after a 50-percent isovolemic exchange transfusion (ET) with diaspirin-crosslinked hemoglobin (alpha alpha Hb). Stroma-free Hb was crosslinked between the alpha chains by using a 14C-labeled diaspirin, bis(3,5-dibromosalicyl)fumarate. Forty conscious, chronically cannulated rats underwent ET with 14C-labeled alpha alpha Hb solution (8.0 g/dL [80 g/L]). This resulted in systemic hypertension for 3 to 4 hours after ET (mean arterial pressure rose from 120 to 145 torr at 1 to 2 hours after ET) and mild bradycardia for 2 to 3 hours (heart rate decreased from 420 to 335 beats/min [bpm] before stabilizing at 360 +/- 10 bpm). This was accompanied by significant diuresis immediately after ET (5- 6-fold increase in urine output, which normalized after 12 hours), and mild hemoglobinuria. The total amount of Hb recovered in the urine was < 5 percent of the injected dose. Reversed-phase high-performance liquid chromatography and sodium dodecyl sulfate-polyacrylamide gel electrophoresis confirmed the presence of crosslinked alpha alpha Hb molecules in the urine. Renal excretion of radioactivity was significantly greater, with 20 percent of total radioactivity being eliminated within 24 hours. The plasma half-life for alpha alpha Hb was 5 hours (administered dose, 2.4 g Hb/kg body weight). Thus, infusion of alpha alpha Hb caused a transient systemic hypertension, and intramolecular crosslinking alone was not enough to exclude completely the filtration of alpha alpha Hb by the kidneys.
Keipert
P E
PE
Division of Blood Research, Letterman Army Institute of Research, Presidio of San Francisco, California.
Gonzales
A
A
Gomez
C L
CL
MacDonald
V W
VW
Hess
J R
JR
Winslow
R M
RM
D000818:Animals; D001241:Aspirin / Q000031:analogs & derivatives*; D001794:Blood Pressure / Q000187:drug effects*; D001802:Blood Substitutes / Q000493:pharmacokinetics / Q000494:pharmacology; D002250:Carbon Radioisotopes; D002851:Chromatography, High Pressure Liquid; D003432:Cross-Linking Reagents; D004231:Diuresis / Q000187:drug effects*; D005078:Exchange Transfusion, Whole Blood; D006207:Half-Life; D006339:Heart Rate / Q000187:drug effects; D007700:Kinetics; D008297:Male; D051381:Rats; D017207:Rats, Sprague-Dawley
D001802:Blood Substitutes; D002250:Carbon Radioisotopes; D003432:Cross-Linking Reagents; C030830:succinyldisalicylic acid; D001241:Aspirin